For trisomy 18, AFP-L2 replacement of AFP decreased the IDI and NRI by 8.12% and 13.84%, and that AFP-L3 replacement of AFP lowered the IDI and NRI by 1.52% and 8.54% in Table 4, respectively. This evidence concerns the gene AFP and trisomy 18.